Autolus Therapeutics plc Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Autolus Therapeutics plc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q3 2024.
  • Autolus Therapeutics plc Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $60.5M, a 1.85% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $60.5M +$1.1M +1.85% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $57.7M +$3.43M +6.32% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $59.1M +$32.3M +120% Mar 31, 2024 10-Q 2024-05-17
Q4 2023 $60.8M +$37.6M +162% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $59.4M +$46.2M +349% Sep 30, 2023 10-K 2024-03-21
Q2 2023 $54.3M +$39M +256% Jun 30, 2023 10-K 2024-03-21
Q1 2023 $26.9M +$9.5M +54.7% Mar 31, 2023 10-K 2024-03-21
Q4 2022 $23.2M +$4.44M +23.6% Dec 31, 2022 10-K 2024-03-21
Q3 2022 $13.2M Sep 30, 2022 10-K 2024-03-21
Q2 2022 $15.2M Jun 30, 2022 10-K 2024-03-21
Q1 2022 $17.4M -$3.83M -18.1% Mar 31, 2022 10-K 2024-03-21
Q4 2021 $18.8M -$32.9M -63.6% Dec 31, 2021 20-F 2023-03-07
Q1 2021 $21.2M -$2.51M -10.6% Mar 31, 2021 6-K 2021-05-06
Q4 2020 $51.6M +$28.2M +121% Dec 31, 2020 20-F 2022-03-10
Q3 2020 $49.5M +$25.4M +105% Sep 30, 2020 6-K 2020-11-05
Q2 2020 $25.1M -$405K -1.59% Jun 30, 2020 6-K 2020-08-06
Q1 2020 $23.7M Mar 31, 2020 6-K 2020-05-07
Q4 2019 $23.4M +$17.8M +318% Dec 31, 2019 20-F 2021-03-04
Q3 2019 $24.1M Sep 30, 2019 6-K 2019-11-07
Q2 2019 $25.5M Jun 30, 2019 6-K 2019-08-08
Q4 2018 $5.6M Jan 1, 2019 20-F 2020-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.